Chembio Diagnostics: David Bespalko
Chembio Diagnostics has appointed David Bespalko to its board of directors. Bespalko brings more than 35 years of leadership experience in the global in vitro diagnostics market, the firm said. Most recently he was group vice president at Thermo Fisher Scientific's Global Commercial Operations Specialty Diagnostics Group. He joined Thermo Fisher in 2011 as president of Fisher Healthcare. At Thermo Fisher, Bespalko held additional roles including president of the firm's Global Anatomical Pathology Division. Previously, he was corporate vice president North America for commercial operations at Beckman Coulter. His diagnostics career began in Canada with commercial and general management roles at Baxter Healthcare and Dade Behring. Bespalko now manages his own consulting firm, BMC, which advises early-stage companies and provides executive mentorship.